Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,653 | -4,228 | -8,720 | -5,189 | -1,822 |
| Depreciation Amortization | 1,884 | 1,884 | 440 | 311 | 175 |
| Accounts receivable | -5 | -39 | N/A | -6 | -13 |
| Other Working Capital | 934 | -1,228 | 1,070 | 1,637 | 226 |
| Other Operating Activity | 231 | -192 | -720 | -836 | -905 |
| Operating Cash Flow | $-6,609 | $-3,803 | $-7,930 | $-4,083 | $-2,338 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -69 | -4 | 180 | 174 | 148 |
| Purchase Of Investment | -34,475 | N/A | -2,821 | N/A | N/A |
| Sale Of Investment | 2,714 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 1 | 0 | 0 |
| Investing Cash Flow | $-31,830 | $-4 | $-2,640 | $174 | $148 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,392 | N/A | N/A |
| Debt Repayment | -2,600 | -2,600 | N/A | N/A | N/A |
| Common Stock Issued | 53,130 | 53,130 | N/A | N/A | N/A |
| Other Financing Activity | -5,201 | -4,811 | 17,188 | 17,776 | 17,779 |
| Financing Cash Flow | $45,329 | $45,719 | $19,580 | $17,776 | $17,779 |
| Beginning Cash Position | 11,006 | 11,006 | 2,000 | 2,001 | 2,001 |
| End Cash Position | 17,896 | 52,918 | 11,000 | 15,868 | 17,590 |
| Net Cash Flow | $6,890 | $41,912 | $9,000 | $13,867 | $15,589 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,609 | -3,803 | -7,930 | -4,083 | -2,338 |
| Capital Expenditure | -69 | -4 | -11 | -7 | -7 |
| Free Cash Flow | -6,678 | -3,807 | -7,941 | -4,090 | -2,345 |